JDRF Call for Proposals: User-Centric Insulin Pumps

Closing Date: 10/05/2022

Funding to develop insulin pumps with improved form factor and other user-centric features that improve user experience so as to enable greater adoption of pumps and artificial pancreas (AP) systems.

The Juvenile Diabetes Research Foundation (JDRF), based in the United States, is an international organisation that funds innovative research to advance the treatment, prevention and cure of Type-one diabetes (T1D).

This Request for Applications – User-Centric Insulin Pumps – is seeking proposals to develop insulin pumps with improved form factor and other “user-centric” features that improve user experience so as to enable greater adoption of pumps and artificial pancreas (AP) systems.

AP (automated insulin delivery (AID) and hybrid closed loop (HCL) systems) provide many benefits for glucose control in diabetes, however there are significant barriers to widespread adoption, including physical and psychological burdens associated with insulin pump use and the ‘on-body’ burden of wearing a pump. JDRF is seeking to develop a more user-centric pump/system that imposes less physical and psychological burden on people with T1D as well as people with type 2 diabetes who use insulin.

Examples of research appropriate for this RFA include, but are not limited to, development of pumps with the following features:

  • Decreased size (for example, due to novel pumping mechanisms) or other improvement in form factor for better user experience
  • Reduced propensity to cause pain and/or dermatological complications
  • Discreet appearance
  • Combined insulin infusion and glucose sensing
  • Simpler or otherwise improved user interactions with device
  • Low cost

JDRF will consider support for user-centric pumps at any stage of development, up to and including pivotal trials and regulatory submissions.

Funding body Juvenile Diabetes Research Foundation (JDRF)
Maximum value 4,500,000 USD
Reference ID S23632
Category Engineering and Physical Sciences
Medical Research

Fund or call Fund